Alnylam Pharmaceuticals, Inc.
Insider Trading: Sales
- 1 - 20
- Next >>
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
RGLS | $16.29 | 446 | Large Shareholder | 5,896,716 | 2014-10-24 | Filing | |
RGLS | $15.50 | 350 | Large Shareholder | 5,897,162 | 2014-10-24 | Filing | |
RGLS | $14.63 | 1,054 | Large Shareholder | 5,897,512 | 2014-10-24 | Filing | |
RGLS | $15.45 | 50 | Large Shareholder | 5,898,566 | 2014-10-23 | Filing | |
RGLS | $14.90 | 450 | Large Shareholder | 5,898,616 | 2014-10-23 | Filing | |
RGLS | $13.94 | 1,200 | Large Shareholder | 5,899,066 | 2014-10-23 | Filing | |
RGLS | $17.11 | 175 | Large Shareholder | 5,900,266 | 2014-10-22 | Filing | |
RGLS | $16.59 | 11,376 | Large Shareholder | 5,900,441 | 2014-10-22 | Filing | |
RGLS | $14.67 | 15,156 | Large Shareholder | 5,911,817 | 2014-10-22 | Filing | |
RGLS | $13.91 | 57,753 | Large Shareholder | 5,926,973 | 2014-10-22 | Filing | |
RGLS | $12.83 | 15,791 | Large Shareholder | 5,984,726 | 2014-10-22 | Filing | |
RGLS | $12.18 | 9,283 | Large Shareholder | 6,000,517 | 2014-10-22 | Filing | |
RGLS | $15.19 | 1,850 | Large Shareholder | 5,896,716 | 2014-10-24 | Filing | |
RGLS | $14.24 | 1,700 | Large Shareholder | 5,898,566 | 2014-10-23 | Filing | |
RGLS | $14.00 | 109,534 | Large Shareholder | 5,900,266 | 2014-10-22 | Filing | |
RGLS | $6.79 | 3,000 | Large Shareholder | 6,009,800 | 2014-10-17 | Filing | |
RGLS | $6.76 | 4,800 | Large Shareholder | 6,012,800 | 2014-10-16 | Filing | |
RGLS | $6.67 | 4,300 | Large Shareholder | 6,017,600 | 2014-10-15 | Filing | |
RGLS | $6.41 | 2,000 | Large Shareholder | 6,021,900 | 2014-10-10 | Filing | |
RGLS | $6.58 | 4,750 | Large Shareholder | 6,023,900 | 2014-10-09 | Filing |
- 1 - 20
- Next >>